Literature DB >> 33852043

Assessment of long-term functional maintenance of primary human hepatocytes to predict drug-induced hepatoxicity in vitro.

Yi Chen1, Dan Tang1, Hongping Wu2, Yuling Wu1, Tianjie Yuan1, Hongdan Zhang3, Yingfu Jiao1, Weifeng Yu4,5, Hexin Yan6,7,8,9.   

Abstract

Hepatocytes are the main cell components of the liver and perform metabolic, detoxification, and endocrine functions. Functional hepatocytes are of great value in drug development, toxicity evaluation, and cell therapy for liver diseases. In recent years, an increasing number of in vitro models have been developed to screen drugs and test their toxicity. However, maintaining hepatocyte function in vitro for a long time is a serious challenge. Even freshly isolated liver cells cultured for a short time may lose function via spontaneous dedifferentiation. Thus, novel cell culture systems allowing extended hepatocyte maintenance and more predictive long-term in vitro studies are required. In this study, we developed a conditioned culture system composed of a small-molecule combination that can maintain hepatocyte morphology and functions over the long term. Two-month culture of primary human hepatocytes showed that the conditioned medium was able to stably preserve hepatic functions such as albumin and α-antitrypsin secretion, hepatic transport activity, urea synthesis, and ammonia elimination. Furthermore, this culture model can be used to assess drug-induced hepatotoxicity in vitro. In summary, our work suggests a feasible approach to maintain hepatocyte function in vitro and proposes a promising model for long-term toxicological studies and drug development.

Entities:  

Keywords:  Drug-induced hepatoxicity; In vitro models; Long-term cell culture; Primary human hepatocyte

Mesh:

Year:  2021        PMID: 33852043     DOI: 10.1007/s00204-021-03050-y

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  65 in total

Review 1.  Drug-induced Cholestasis: Mechanisms, Models, and Markers.

Authors:  Sagnik Chatterjee; Pieter Annaert
Journal:  Curr Drug Metab       Date:  2018       Impact factor: 3.731

Review 2.  The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.

Authors:  Naga Chalasani; Zobair Younossi; Joel E Lavine; Michael Charlton; Kenneth Cusi; Mary Rinella; Stephen A Harrison; Elizabeth M Brunt; Arun J Sanyal
Journal:  Hepatology       Date:  2017-09-29       Impact factor: 17.425

Review 3.  Burden of liver diseases in the world.

Authors:  Sumeet K Asrani; Harshad Devarbhavi; John Eaton; Patrick S Kamath
Journal:  J Hepatol       Date:  2018-09-26       Impact factor: 25.083

4.  Developing scalable cultivation systems of hepatic spheroids for drug metabolism via genomic and functional analyses.

Authors:  Jiwon Ahn; Ho-Joon Lee; Soo Jin Oh; Wantae Kim; Seon Ju Mun; Jae-Hye Lee; Cho-Rock Jung; Hyun-Soo Cho; Dae-Soo Kim; Myung Jin Son; Kyung-Sook Chung
Journal:  Biotechnol Bioeng       Date:  2019-03-04       Impact factor: 4.530

5.  Hepatocyte-based in vitro model for assessment of drug-induced cholestasis.

Authors:  Sagnik Chatterjee; Lysiane Richert; Patrick Augustijns; Pieter Annaert
Journal:  Toxicol Appl Pharmacol       Date:  2013-11-07       Impact factor: 4.219

6.  HTSeq--a Python framework to work with high-throughput sequencing data.

Authors:  Simon Anders; Paul Theodor Pyl; Wolfgang Huber
Journal:  Bioinformatics       Date:  2014-09-25       Impact factor: 6.937

7.  Low temperature magneto-morphological characterisation of coronene and the resolution of previously observed unexplained phenomena.

Authors:  Jason Potticary; Rebecca Boston; Liana Vella-Zarb; Alex Few; Christopher Bell; Simon R Hall
Journal:  Sci Rep       Date:  2016-12-07       Impact factor: 4.379

8.  Transcriptional, Functional, and Mechanistic Comparisons of Stem Cell-Derived Hepatocytes, HepaRG Cells, and Three-Dimensional Human Hepatocyte Spheroids as Predictive In Vitro Systems for Drug-Induced Liver Injury.

Authors:  Catherine C Bell; Volker M Lauschke; Sabine U Vorrink; Henrik Palmgren; Rodger Duffin; Tommy B Andersson; Magnus Ingelman-Sundberg
Journal:  Drug Metab Dispos       Date:  2017-01-30       Impact factor: 3.922

9.  Comparison of Hepatic 2D Sandwich Cultures and 3D Spheroids for Long-term Toxicity Applications: A Multicenter Study.

Authors:  Catherine C Bell; Anita C A Dankers; Volker M Lauschke; Rowena Sison-Young; Roz Jenkins; Cliff Rowe; Chris E Goldring; Kevin Park; Sophie L Regan; Tracy Walker; Chris Schofield; Audrey Baze; Alison J Foster; Dominic P Williams; Amy W M van de Ven; Frank Jacobs; Jos van Houdt; Tuula Lähteenmäki; Jan Snoeys; Satu Juhila; Lysiane Richert; Magnus Ingelman-Sundberg
Journal:  Toxicol Sci       Date:  2018-04-01       Impact factor: 4.849

10.  LCAT protects against Lipoprotein-X formation in a murine model of drug-induced intrahepatic cholestasis.

Authors:  Marcelo J A Amar; Lita A Freeman; Takafumi Nishida; Maureen L Sampson; Milton Pryor; Boris L Vaisman; Edward B Neufeld; Sotirios K Karathanasis; Alan T Remaley
Journal:  Pharmacol Res Perspect       Date:  2019-12-29
View more
  2 in total

1.  Talaromyces marneffei activates the AIM2-caspase-1/-4-GSDMD axis to induce pyroptosis in hepatocytes.

Authors:  Gang Wang; Wudi Wei; Zhongsheng Jiang; Junjun Jiang; Jing Han; Hong Zhang; Jiaguang Hu; Peng Zhang; Xu Li; Tao Chen; Jinhao He; Zhen Li; Jingzhen Lai; Hao Liang; Chuanyi Ning; Li Ye
Journal:  Virulence       Date:  2022-12       Impact factor: 5.428

Review 2.  In Vitro Models for Studying Chronic Drug-Induced Liver Injury.

Authors:  M Teresa Donato; Gloria Gallego-Ferrer; Laia Tolosa
Journal:  Int J Mol Sci       Date:  2022-09-28       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.